Assessment of Endothelial Function in Patients with COVID-19 Using Peripheral Arterial Tonometry

There is increasing evidence that COVID-19 induces endothelial dysfunction that may precede thrombotic and cardiovascular complications. The aim of this study is to evaluate endothelial function using peripheral arterial tonometry (EndoPAT). The primary endpoint is the hyperemic vascular response in...

Full description

Saved in:
Bibliographic Details
Main Authors: Athanasios Moulias, Rafail Koros, Angeliki Papageorgiou, Spyridon Katechis, Panagiotis Patrinos, Aikaterini Trigka-Vasilakopoulou, Athanasios Papageorgiou, Ourania Papaioannou, Karolina Akinosoglou, Georgios Leventopoulos, Grigorios Tsigkas, Argyrios Tzouvelekis, Periklis Davlouros
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/14/11/1512
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is increasing evidence that COVID-19 induces endothelial dysfunction that may precede thrombotic and cardiovascular complications. The aim of this study is to evaluate endothelial function using peripheral arterial tonometry (EndoPAT). The primary endpoint is the hyperemic vascular response index (LnRHI) at two months post-discharge. Secondary endpoints include the LnRHI during hospitalization and at six-month follow-up, the proportion of patients with endothelial dysfunction (LnRHI ≤ 0.51), and the incidence of thrombotic events, cardiovascular complications, and mortality during the follow-up period. The study included 23 COVID-19 patients and 22 COVID-19-negative, matched controls. The patients exhibited a significant reduction in the LnRHI at two months post-discharge compared to the controls (median = 0.55 [IQR: 0.49–0.68] vs. median = 0.70 [IQR: 0.62–0.83]; <i>p</i> = 0.012). The difference in the LnRHI between patients and controls was evident from hospitalization and persisted at two and six months without significant temporal changes. The proportion of COVID-19 patients with endothelial dysfunction (LnRHI ≤ 0.51) was 61% during hospitalization and 55% at six months. There was no significant difference in thrombotic or cardiovascular events, nor in mortality. This study demonstrates that COVID-19 adversely affects endothelial function, as evidenced by a reduction in the hyperemic vascular response index, and endothelial dysfunction may also persist.
ISSN:2075-1729